Target intelligence / Profile preview

Calcium binding protein 39-like mRNA 3'-untranslated region (CAB39L mRNA 3'-UTR)

Target
CAB39L mRNA 3'-UTR
Molecular classification
mRNA, Untranslated region, Regulatory RNA element, Other
01

Overview

The Calcium binding protein 39-like (CAB39L) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the CAB39L transcript that governs the expression of the CAB39L protein, also known as MO25-beta (UniProt: Q9H9S4). CAB39L serves as a vital scaffold component of the LKB1-STRAD-CAB39L heterotrimeric complex, which is necessary for the full activation of Liver Kinase B1 (LKB1), a master upstream kinase of the AMP-activated protein kinase (AMPK) family (NCBI Gene: 27279). The 3'-UTR of CAB39L contains multiple seed sequences for microRNAs, such as miR-107 and miR-497, which negatively regulate its expression through translational inhibition or mRNA decay (PubMed: 25670101). In various malignancies, including gastric cancer and nasopharyngeal carcinoma, the downregulation of CAB39L via its 3'-UTR is associated with increased cell proliferation, migration, and resistance to apoptosis (PubMed: 29130515). Consequently, the CAB39L mRNA 3'-UTR is an emerging focal point for RNA-based therapeutic interventions designed to modulate the LKB1/AMPK signaling axis in cancer and metabolic diseases. Experimental strategies targeting this region include miRNA mimics to suppress oncogenic signaling or antisense oligonucleotides to stabilize the transcript in tumor-suppressive contexts.

Other names
MO25L mRNA 3'-UTRMO25-beta mRNA 3'-UTRCalcium binding protein 39-like 3'-UTRCAB39L 3'-UTR
02

Mechanism of action

MicroRNA-mediated gene silencing or antisense-mediated modulation of mRNA stability and translation to regulate CAB39L protein levels.

03

Biological functions

Regulation of mRNA stabilityRegulation of translationSignal transductionCell proliferationOther
04

Disease associations

CancerGastric cancerNasopharyngeal carcinomaGliomaOther
05

Safety considerations

Off-target effects of RNA-based therapiesDelivery efficiency to specific tumor tissuesPotential for systemic inflammatory responses to synthetic oligonucleotidesSaturation of the endogenous RNAi machinery
06

Interacting drugs

miR-107 mimics (experimental)

2 more in the full profile.

07

Biomarkers

CAB39L mRNA expression levelsmiR-107 expression levelsmiR-497 expression levels

Beyond the preview

Go deeper on Calcium binding protein 39-like mRNA 3'-untranslated region (CAB39L mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium binding protein 39-like mRNA 3'-untranslated region (CAB39L mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call